期刊文献+

透明质酸钠、肉毒素A治疗女性IC/PBS疗效观察 被引量:3

Curative effect of sodium hyaluronate and botulinum toxin A in female patients with IC/PBS
下载PDF
导出
摘要 目的观察膀胱灌注透明质酸钠、膀胱内注射肉毒素A治疗女性间质性膀胱炎/膀胱疼痛综合征(IC/PBS)的疗效。方法 41例女性IC/PBS患者,其中行透明质酸钠膀胱灌注22例(A组),行肉毒素A膀胱内注射19例(B组)。评估患者治疗前及治疗后1、3、6个月临床症状(每日排尿次数、最大排尿量、疼痛程度评分)及O'Leary-Sant间质性膀胱炎问卷表评分情况,并记录不良反应发生情况。结果两组患者治疗后各时间点每日排尿次数、最大排尿量、疼痛程度评分、O'Leary-Sant评分与治疗前相比P均<0.05。治疗后6个月上述指标B组与A组相比P均<0.05,而治疗前及治疗后1个月两组比较P均>0.05。A组未出现严重不良反应。B组3例第3个月出现排尿困难,后逐渐改善,无其他不良反应。A、B组分别有2、1例在水扩张之后出现轻微肉眼血尿,后逐渐消失。A组有1例因心脏病中断治疗,其余患者均完成治疗及随访。结论膀胱内灌注透明质酸钠能有效缓解IC/PBS患者临床症状,改善其生活质量,患者耐受性及安全性较好。膀胱内注射肉毒素A短期内能缓解症状,但疗效随时间的推移进行性下降,且伴随少量不良反应的发生,不良反应随着药效的减退而逐渐改善。 Objective To observe the safety and efficacy of instillation of sodium hyaluronate therapy and intravesical botulinum toxin A(BTX-A) injections for the female patients with interstitial cystitis /painful bladder syndrome(IC /PBS).Methods There were 41 IC /PBS patients in total.22 patients were given instillation of sodium hyaluronate therapy(group A).Other 19 patients received BTX-A injections(group B).Clinical symptoms(micturition frequency per day,maximal micturition volume and odynuria degree score),O'Leary-Sant symptom and problem index were assessed at baseline and then again after 1,3 and 6 months.Side effects were recorded.Compare two therapies,curative effect and side effects,and assess their safety and efficacy.Results Before therapy and after therapy,clinical symptoms,O'Leary-Sant symptom and problem index of both groups patients,had significant differences(P0.05).After 3 and 6 months,there were significant differences between two groups(P0.05).Before therapy and after 1 month,clinical symptoms,O'Leary-Sant symptom and problem index between two groups had no significant differences(P0.05).Instillation of sodium hyaluronate therapy had no adverse effects.There were three patients who got dysuria in BTX-A injections group,no other side effects.Conclusions Instillation of sodium hyaluronate therapy can effectively relieve clinical symptom of IC/PBS and improve patients,quality of life and is well tolerated.It had a longer effect.Intravesical BTX-A injections had a short-term benefit,and it caused some side effects such as dysuria and voiding difficulty,which lasted several months until the effect of the treatment wore off.
出处 《山东医药》 CAS 北大核心 2011年第6期15-17,共3页 Shandong Medical Journal
关键词 间质性膀胱炎 膀胱疼痛综合征 透明质酸钠 肉毒素A interstitial cystitis painful bladder syndrome sodium hyaluronate botulinum toxin A
  • 相关文献

参考文献5

  • 1Rothrock NE, Lutgendorf SK, Kreder KJ. Coping Strategies in pa- tients with interstitial cystitis : relationships with quality of life and depression[J]. J Urol, 2003,169( 1 ) : 233-236.
  • 2Nickel JC, Shoskes DA, Irvine-Bird K, et al . Prevalence and im- pact of baeteriuria and/or urinary tract infection in interstitial cys- titis/painful bladder syndrome[J]. Urology, 2010, 76 (4) : 799- 803.
  • 3Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistenfion with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syn- drome[J]. BJU Int, 2009, 104 (5) : 657-661.
  • 4Shao Y, Shen ZJ, Rui WB, et al. Intravesical instillation of hyalu- tonic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis[J]. Urology, 2010, 75 (3) : 547- 551.
  • 5Baykara M , Erdogru T, Gutke~n KH ,et al. Does interstitial cystitis urine include possible factors effecting the nociceptive system of the spinal cord[J]. Urol Int, 2003, 71 (1) : 66-72.

同被引文献39

  • 1李昕,李宁忱,丁强,蔡松良,霍红旭,陈昭彦,顾晓箭,陈仕平,那彦群.α_1肾上腺素能受体阻滞剂萘哌地尔治疗慢性非细菌性前列腺炎的临床研究[J].中华男科学杂志,2006,12(3):234-236. 被引量:32
  • 2叶章群,蓝儒竹,王少刚,蔡松良,陈戈明,李宁忱,宋毅,那彦群.舍尼通~和抗生素联合用药治疗慢性非细菌性前列腺炎临床研究[J].中华男科学杂志,2006,12(9):807-810. 被引量:21
  • 3Wagenlehener FM, Waber KG. Antimicrebial treatment of pros- tatitis. Expert Rev Anti Infect Ther, 2003, 2 (1) : 275-282.
  • 4Zhao WP, Zhang ZG, Li XP, et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain symdrome ( Category III A). Braz J Med Biol Res. 2009, 42 (10) : 963-967.
  • 5Hampel C, Dolber PC, Smith MP, et al. Modulation of bladder alpha 1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol, 2002, 157(3) : 1513-1521.
  • 6Nishino Y, Masue T, Miwa K, et al. Comparison of two alphal - adrenoceptor antagonists, naftopidil and tamsulosin hydrochlo- ride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: A randomized crossover study. BJU Int, 2006, 97(4) : 747-751.
  • 7Komiya A, Suzuki H, Awa Y, et al. Clinical effect of naftopidil on the quality of life of patients with low urinary tract symptoms suggestive of benign prostatic hyperplasia: "A prospective study. Int J Urol, 2010, 17(6) : 555-562.
  • 8Dawson TE,Jamison J.Intravesical treatments for painful bladder syndrome/interstitial cystitis.Co-chrane Database Syst Rev,2007:CD006113.
  • 9Hanno P,Lin A,Nordling J,et al.Bladder Pain Syndrome Committee of the International Consul-tation on Incontinence.Neurourol Urodyn,2010,29:191~198.
  • 10Riedl CR,Engelhardt PF,Daha KL,et al.Hyaluro-nan treatment of interstitial cystitis/painful bladdersyndrome.Int Urogynecol J Pelvic Floor Dysfunct,2008,19:717~721.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部